Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial

Clinical Endocrinology

Volumn 82, Issue 6, 2015, Pages 885-891

  Jamilian, Mehri ^a   Razavi, Maryamalsadat ^b   Fakhrie Kashan, Zohreh ^c   Ghandi, Yasser ^c   Bagherian, Tayebeh ^c   Asemi, Zatollah ^c  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; GLUCOSE; INSULIN; PLACEBO; SELENIUM; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; TRACE ELEMENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUHOMEOSTATIC MODEL ASSESSMENT OF BETA CELL FUNCTION; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLISM; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; BLOOD; DIETARY SUPPLEMENT; DRUG MONITORING; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

ADOLESCENT; ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; SELENIUM; TRACE ELEMENTS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84929707089     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12699     Document Type: Article

References (34)

1. Luque-Ramirez, M., &, Escobar-Morreale, H.F., (2014) Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity. Current Hypertension Reports, 16, 500.
2. Cassar, S., Teede, H.J., Harrison, C.L., et al,. (2014) Biomarkers and insulin sensitivity in women with PCOS: characteristics and predictive capacity. Clinical Endocrinology (Oxford), doi: 10.1111/cen.12619 [Epub ahead of print].
3. Unfer, V., &, Porcaro, G., (2014) Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology, 7, 623-631.
4. Dunaif, A., Segal, K.R., Futterweit, W., et al,. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
5. Dale, P.O., Tanbo, T., Vaaler, S., et al,. (1992) Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertility and Sterility, 58, 487-491.
6. Talbott, E.O., Zborowski, J.V., Sutton-Tyrrell, K., et al,. (2001) Cardiovascular risk in women with polycystic ovary syndrome. Obstetrics and Gynecology Clinics of North America 28, 111-133, vii.
7. Dahlgren, E., Janson, P.O., Johansson, S., et al,. (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstetricia et Gynecologica Scandinavica, 71, 599-604.
8. Lu, J., &, Holmgren, A., (2009) Selenoproteins. Journal of Biological Chemistry, 284, 723-727.
9. Reddi, A.S., &, Bollineni, J.S., (2001) Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney International, 59, 1342-1353.
10. Stapleton, S.R., (2000) Selenium: an insulin-mimetic. Cellular and Molecular Life Sciences, 57, 1874-1879.
11. Alizadeh, M., Safaeiyan, A., Ostadrahimi, A., et al,. (2012) Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Annals of Nutrition & Metabolism, 60, 157-168.
12. Kang, B.P., Bansal, M.P., &, Mehta, U., (2000) Hyperlipidemia and type I 5′-monodeiodinase activity: regulation by selenium supplementation in rabbits. Biological Trace Element Research, 77, 231-239.
13. Faghihi, T., Radfar, M., Barmal, M., et al,. (2014) A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes: effects on glucose homeostasis, oxidative stress, and lipid profile. American Journal of Therapeutics, 21, 491-495.
14. Li, Y.B., Han, J.Y., Jiang, W., et al,. (2011) Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells. Molecular Biology Reports, 38, 2301-2306.
15. Brigelius-Flohe, R., Banning, A., Kny, M., et al,. (2004) Redox events in interleukin-1 signaling. Archives of Biochemistry and Biophysics, 423, 66-73.
16. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81, 19-25.
17. Hatch, R., Rosenfield, R.L., Kim, M.H., et al,. (1981) Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology, 140, 815-830.
18. Ramezani Tehrani, F., Minooee, S., &, Azizi, F., (2014) Validation of a simplified method to assess hirsutism in the Iranian population. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 174, 91-95.
19. Pisprasert, V., Ingram, K.H., Lopez-Davila, M.F., et al,. (2013) Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care, 36, 845-853.
20. Burk, R.F., Norsworthy, B.K., Hill, K.E., et al,. (2006) Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiology, Biomarkers & Prevention, 15, 804-810.
21. Aldosary, B.M., Sutter, M.E., Schwartz, M., et al,. (2012) Case series of selenium toxicity from a nutritional supplement. Clinical Toxicology (Philadelphia, Pa.), 50, 57-64.
22. Bargiota, A., &, Diamanti-Kandarakis, E., (2012) The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Therapeutic Advances in Endocrinology and Metabolism, 3, 27-47.
23. Wang, C., Yang, S., Zhang, N., et al,. (2014) Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS ONE, 9, e101315.
24. Campbell, S.C., Aldibbiat, A., Marriott, C.E., et al,. (2008) Selenium stimulates pancreatic beta-cell gene expression and enhances islet function. FEBS Letters, 582, 2333-2337.
25. Legro, R.S., (2003) Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Reviews, 24, 302-312.
26. Flores-Mateo, G., Navas-Acien, A., Pastor-Barriuso, R., et al,. (2006) Selenium and coronary heart disease: a meta-analysis. American Journal of Clinical Nutrition, 84, 762-773.
27. Brown, B.G., Zhao, X.Q., Chait, A., et al,. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. New England Journal of Medicine, 345, 1583-1592.
28. Hercberg, S., (2006) The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health. Annales Pharmaceutiques Francaises, 64, 397-401.
29. Wojcicki, J., Rozewicka, L., Barcew-Wiszniewska, B., et al,. (1991) Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis, 87, 9-16.
30. Kaur, H.D., &, Bansal, M.P., (2009) Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation. Lipids in Health and Disease, 8, 55.
31. Cheung, M.C., Zhao, X.Q., Chait, A., et al,. (2001) Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1320-1326.
32. Boskabadi, H., Maamouri, G., Rezagholizade Omran, F., et al,. (2012) Effect of prenatal selenium supplementation on cord blood selenium and lipid profile. Pediatrics and Neonatology 53, 334-339.
33. Kim, J.E., Choi, S.I., Lee, H.R., et al,. (2012) Selenium significantly inhibits adipocyte hypertrophy and abdominal fat accumulation in OLETF rats via induction of fatty acid beta-oxidation. Biological Trace Element Research, 150, 360-370.
34. Tsouma, I., Kouskouni, E., Demeridou, S., et al,. (2014) Lipid lipoprotein profile alterations in Greek infertile women with polycystic ovaries: influence of adipocytokines levels. In Vivo, 28, 935-939.